SEC FIlings Archives - Page 17 of 19

16 Aug

SEC FIlings

Notification of of late filing

November 17, 2022
Posted by Jitendra

23 Jul

SEC FIlings

Quarterly report for quarter ending Mar 31, 2021

November 17, 2022
Posted by Jitendra

01 Jun

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

17 May

SEC FIlings

Notification of late filing

November 17, 2022
Posted by Jitendra

31 Mar

SEC FIlings

Annual report for fiscal year ending Dec 31, 2020

November 17, 2022
Posted by Jitendra

08 Mar

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

15 Jan

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

14 Jan

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

11 Jan

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

08 Jan

SEC FIlings

Prospectus

November 17, 2022
Posted by Jitendra

SEC FIlings

Notification of of late filing

Quarterly report for quarter ending Mar 31, 2021

Current report

Notification of late filing

Annual report for fiscal year ending Dec 31, 2020

Statement of acquisition of beneficial ownership by individuals

Current report

Statement of acquisition of beneficial ownership by individuals

Current report

Prospectus

test according

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information

Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists